Novacyt

Novacyt Group is an Anglo-French biotechnology group focused on clinical diagnostics, with offices in Camberley, Surrey, United Kingdom and Vélizy-Villacoublay, France.[1][2] The company produces in vitro and molecular diagnostic tests, supplying an extensive range assays and reagents worldwide.[3] Its business units include Primerdesign (a University of Southampton Medical School spin-off company founded in 2005 by Dr Jim Wicks, Dr Rob Powell and Professor Tom Brown)[4][5], Microgen Bioproducts and Lab21 Healthcare.[6]

Novacyt S.A.
Société Anonyme
Traded asLSE: NCYT
Euronext: ALNOV
IndustryBiotechnology
Founded2006
HeadquartersCamberley, Surrey, United Kingdom
Key people
Graham Mullis (CEO)
ProductsIn vitro and molecular diagnostics
Subsidiaries
Websitewww.novacyt.com

In January 2020 the company announced that its molecular diagnostics division, Primerdesign, had launched a molecular test for the 2019 strain of SARSr-CoV.[7][8][9][10]. The test was approved as eligible for procurement under the World Health Organization's (WHO) Emergency Use Listing process in April 2020,[11] meaning that the test can be supplied by the United Nations and other procurement agencies supporting the COVID-19 response.[12] In the same month Novacyt announced a collaboration with AstraZeneca, GlaxoSmithKline and the University of Cambridge to support the UK in its COVID-19 national screening programme at a new testing laboratory at the university's Anne McLaren laboratory.[13][14]

References
  1. "Offices". Novacyt. Retrieved 1 February 2020.
  2. "How dangerous is the coronavirus and how does it spread?". Financial Times. Retrieved 1 February 2020.
  3. "Novacyt launches research-only Wuhan virus test". The Standard (Hong Kong). Retrieved 1 February 2020.
  4. "British company racing to contain Ebola". University of Southampton. Retrieved 19 February 2020.
  5. "Novacyt to Acquire Primer Design for Up to $17.6M". Genetic Engineering and Biotechnology News. Retrieved 19 February 2020.
  6. "Annual Report and Accounts for the year ended December 2018" (PDF). Novacyt. Retrieved 1 February 2020.
  7. "Healthcare Company Novacyt Launches New Coronavirus Test". The New York Times. Retrieved 1 February 2020.
  8. "Novacyt shares jump 32% on launch of coronavirus test". CNBC. Retrieved 1 February 2020.
  9. "Chandlers Ford company Primerdesign launch novel coronavirus test". Southern Daily Echo. Retrieved 1 February 2020.
  10. "Novacyt in prime position with coronavirus test". The Times. Retrieved 8 February 2020.
  11. "WHO approves Novacyt's coronavirus testing kit". The Jerusalem Post. Retrieved 8 April 2020.
  12. "WHO lists two COVID-19 tests for emergency use". World Health Organization. Retrieved 10 April 2020.
  13. "Novacyt's Covid-19 diagnostic test gets OK for WHO procurement". London South East. Retrieved 8 April 2020.
  14. "Novacyt joins AstraZeneca and GSK in UK effort on COVID-19 testing". The Pharma Letter. Retrieved 8 April 2020.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.